Cumberland Pharmaceuticals recently announced the addition of Vibativ® (telavancin) to its growing product lineup. The Nashville-headquartered specialty pharmaceutical company entered into a definitive agreement to acquire Vibativ from Theravance Biopharma in the fourth quarter of 2018.
About one in 25 patients in America has at least one healthcare-associated infection (HAI) on any given day, according to the most recent statistics from the Centers for Disease Control and Prevention.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: